IGC Pharma Inc (IGC)
0.3525
+0.02
(+5.76%)
USD |
NYAM |
Nov 21, 16:00
0.3561
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Market Cap: 27.30M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 27.30M |
| November 20, 2024 | 25.81M |
| November 19, 2024 | 26.57M |
| November 18, 2024 | 27.18M |
| November 15, 2024 | 26.26M |
| November 14, 2024 | 27.70M |
| November 13, 2024 | 28.44M |
| November 12, 2024 | 29.52M |
| November 11, 2024 | 29.43M |
| November 08, 2024 | 29.59M |
| November 07, 2024 | 29.74M |
| November 06, 2024 | 29.03M |
| November 05, 2024 | 29.20M |
| November 04, 2024 | 28.88M |
| November 01, 2024 | 29.53M |
| October 31, 2024 | 29.88M |
| October 30, 2024 | 30.56M |
| October 29, 2024 | 30.35M |
| October 28, 2024 | 31.04M |
| October 25, 2024 | 30.34M |
| October 24, 2024 | 29.89M |
| October 23, 2024 | 30.26M |
| October 22, 2024 | 31.51M |
| October 21, 2024 | 30.65M |
| October 18, 2024 | 29.93M |
| Date | Value |
|---|---|
| October 17, 2024 | 30.70M |
| October 16, 2024 | 31.19M |
| October 15, 2024 | 28.74M |
| October 14, 2024 | 28.02M |
| October 11, 2024 | 27.98M |
| October 10, 2024 | 28.35M |
| October 09, 2024 | 27.77M |
| October 08, 2024 | 27.96M |
| October 07, 2024 | 28.43M |
| October 04, 2024 | 28.39M |
| October 03, 2024 | 27.74M |
| October 02, 2024 | 29.54M |
| October 01, 2024 | 29.53M |
| September 30, 2024 | 32.72M |
| September 27, 2024 | 26.78M |
| September 26, 2024 | 26.47M |
| September 25, 2024 | 25.81M |
| September 24, 2024 | 26.00M |
| September 23, 2024 | 25.96M |
| September 20, 2024 | 26.62M |
| September 19, 2024 | 26.37M |
| September 18, 2024 | 25.72M |
| September 17, 2024 | 26.58M |
| September 16, 2024 | 26.59M |
| September 13, 2024 | 26.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
11.86M
Minimum
Mar 18 2020
140.64M
Maximum
Feb 10 2021
38.62M
Average
28.17M
Median
Market Cap Benchmarks
| CEL-SCI Corp | 37.17M |
| AIM ImmunoTech Inc | 13.49M |
| NovaBay Pharmaceuticals Inc | 3.517M |
| Protalix BioTherapeutics Inc | 122.23M |
| Palatin Technologies Inc | 18.35M |
Market Cap Related Metrics
| PS Ratio | 20.62 |
| Price to Book Value | 3.701 |
| Price | 0.3525 |
| Earnings Yield | -51.06% |